New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
08:17 EDTSPASparton to manufacture PathoGenetix RESOLUTION microbial genotyping system
Sparton has been chosen by PathoGenetix as the design and manufacturing partner for their RESOLUTION microbial genotyping system. PathoGenetix is a developer of an automated system for rapid bacterial strain typing. Under the terms of the agreement, Sparton will conduct design for manufacture and pilot production of a limited number of pre-commercial instruments for the RESOLUTION System, which is slated for commercial availability in late 2014. Pre-commercial units of the RESOLUTION System are currently undergoing testing and evaluation by government and food industry partners.
News For SPA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 17, 2015
08:17 EDTSPASparton acquires
Sparton announced that its wholly owned subsidiary, Sparton of Canada, completed the acquisition of substantially all of the assets of on March 16 in an all-cash transaction. “We have amassed a business in which we expect synergies to benefit our customers, our operations, and our product development.’s revenue is expected to enhance the company’s Engineered Components & Products segment EBITDA and be accretive to earnings within the next nine to 12 months, once integration activities are completed,” said Sparton. The transaction was funded through Sparton’s borrowings under the credit facility currently in place.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use